Apply of Diclofenac Sodium and Water Separation Combined with Nuclear Transfer Technique in Phacoemulsification

YE Chun-hua

doi:10.11653/syfj2013120326

您当前的位置：

首页 >

文章列表页 >

Apply of Diclofenac Sodium and Water Separation Combined with Nuclear Transfer Technique in Phacoemulsification

更新时间：2024-01-04

- Apply of Diclofenac Sodium and Water Separation Combined with Nuclear Transfer Technique in Phacoemulsification
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 12, Pages: 326-328(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013120326
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
YE Chun-hua. Apply of Diclofenac Sodium and Water Separation Combined with Nuclear Transfer Technique in Phacoemulsification[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(12): 326-328.
DOI：

YE Chun-hua. Apply of Diclofenac Sodium and Water Separation Combined with Nuclear Transfer Technique in Phacoemulsification[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(12): 326-328. DOI： 10.11653/syfj2013120326.

摘要

目的: 分析双氯芬酸钠水分离联合转核技术在白内障超声乳化术中的应用效果。方法: 取浙江缙云县第二人民医院眼科于2010年4月至2012年4月期间住院收治的160例白内障患者作为研究对象

根据治疗时具体操作不同分为观察组与对照组患者

比较两组患者的角膜内皮细胞计数、后发性白内障分级、手术前后平均眼压和平均视力等差异。结果: 观察组患者的术后1周角膜内皮细胞计数(2 227.37±163.28) 个/mm2、3个月角膜内皮细胞计数(2 186.47±175.85) 个/mm2

与对照组比较无明显差异;观察组患者接受治疗后的后发性白内障分级明显低于对照组患者(P<0.05);观察组患者接受治疗后的平均眼压(10.32±2.34) mmHg和平均视力(0.48±0.13)均明显优于对照组患者(P<0.05)。结论: 双氯芬酸钠水分离联合转核技术可以有效提高白内障超声乳化术的安全性及治疗效果。

Abstract

Objective: To analysis of diclofenac sodium and water separation combined with nuclear transfer technique in phacoemulsification technique application effect. Method: The hospital department of ophthalmology in 2010 April to 2012 April during the hospital treated 160 cases of cataract patients as research object

according to the treatment of specific operation is divided into the observation group and the control group with 80 cases

comparing the two groups of patients with corneal endothelial cell count

after primary cataract grading

mean intracular pressure(IOP) and before and after operation the average visual difference. Result: The patients in the observation group after 1 weeks of March and the corneal endothelial cell count and patients in the control group had no significant difference; the patients in the observation group after treatment of after cataract grading was significantly lower than that of control group (P<0.05); the patients in the observation group received treatment after a mean intraocular pressure and mean visual acuity were significantly better than the patients in the control group (P<0.05). Conclusion: Diclofenac sodium and water separation joint nuclear transfer technology can effectively improve the phacoemulsification for safety and effectiveness.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Source， Structure， Biological Activity and Application of Natural Arabinogalactan： A Review

Research Progress on Dysemenorrhea of Essential Oils of Traditional Chinese Medicine： A Review

Nardostachys jatamansi， A Medicinal Plant from Qinghai-Tibet Plateau： A Review

Literature Research on Origin and Application of Classical Prescription Xiebaisan

Progress in Treatment of Respiratory Infectious Diseases with Chinese Medicine Injection Recommended in Diagnosis and Treatment Protocol for Coronavirus Disease-2019

Related Author

SU Rina

BAI Wenming

MU Dan

ZHANG Man

ZHAO Peng

Pan XU

Ming YANG

Shuo ZENG

Related Institution

Inner Mongolia Medical University

Key Laboratory of Modern Chinese Medicine Preparation of Ministry of Education， Jiangxi University of Chinese Medicine

Chengdu Railway Health School

Industrial Crop Research Institute，Sichuan Academy of Agricultural Sciences

Sichuan Academy of Grassland Sciences

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰